Today: 7 February 2026
Subscribe
Browse Category

Earnings Reports News 6 January 2026

Amphenol (APH) stock steadies after sharp swing with earnings in view

Amphenol (APH) stock steadies after sharp swing with earnings in view

Amphenol shares climbed 0.4% to $140.40 Tuesday after rebounding from an intraday low of $130.70. The company will pay a $0.25 per share dividend Jan. 7 and reports Q4 results Jan. 28. A Zacks note put 2026 earnings estimates at $4 a share and the stock at 35 times forward earnings. Traders watched for stability near $140 as volatility persisted in AI infrastructure stocks.
6 January 2026
··
Spotify (SPOT) stock slides 3% in regular trade as investors eye jobs data and Feb. 10 earnings

Spotify (SPOT) stock slides 3% in regular trade as investors eye jobs data and Feb. 10 earnings

Spotify shares fell 3.3% to $574.00 by midafternoon Tuesday, underperforming the broader market. Trading volume was below average ahead of Friday’s U.S. jobs data. The drop reversed Monday’s gains and put the stock back below $600. Spotify launched a podcast campaign tied to the Golden Globes and introduced a Governors Ball feature in its app.
6 January 2026
··
Microchip stock jumps nearly 10% after chipmaker lifts sales outlook on strong orders

Microchip stock jumps nearly 10% after chipmaker lifts sales outlook on strong orders

Microchip Technology shares jumped 10% to $73.75 Tuesday after the company raised its fiscal Q3 sales forecast to about $1.185 billion, topping its previous outlook. The move followed a 5.6% after-hours gain Monday. CEO Steve Sanghi cited strong bookings and lower internal inventory. The rally boosted other chipmakers, including Texas Instruments and NXP Semiconductors.
6 January 2026
···
Johnson & Johnson stock ticks up on lupus drug data as earnings loom

Johnson & Johnson stock ticks up on lupus drug data as earnings loom

Johnson & Johnson shares rose 0.5% to $205.41 midday Tuesday after reporting positive Phase 2b results for its lupus drug nipocalimab and announcing plans for Phase 3 trials. The company also filed in Europe to expand use of its myeloma drug combo Tecvayli and Darzalex. J&J continues to face pressure from ongoing talc litigation, with more trials expected this year.
6 January 2026
···
Microchip Technology stock jumps 10% after MCHP boosts Q3 sales outlook

Microchip Technology stock jumps 10% after MCHP boosts Q3 sales outlook

Microchip Technology shares jumped 10.2% to $73.93 after the company raised its fiscal Q3 net sales outlook to about $1.185 billion, above its prior forecast. CEO Steve Sanghi cited strong bookings and a higher March-quarter backlog. The company will release full results Feb. 5 and filed an 8-K update with regulators. Several analysts raised price targets following the announcement.
6 January 2026
····
Bank of America stock edges higher after Barclays target hike as earnings near

Bank of America stock edges higher after Barclays target hike as earnings near

Bank of America shares rose 0.4% to $57.15 midday Tuesday after Barclays and JPMorgan raised their price targets. Citigroup gained 0.5%, Wells Fargo slipped 0.4%, and JPMorgan was flat. Investors await Friday’s U.S. jobs report and Bank of America’s Jan. 14 earnings for direction. Morgan Stanley filed to launch bitcoin and solana ETFs as banks expand into digital assets.
6 January 2026
··
Lumentum stock whipsaws as accounting chief retirement, Feb. 3 earnings date draw focus

Lumentum stock whipsaws as accounting chief retirement, Feb. 3 earnings date draw focus

Lumentum Holdings shares rose 5.2% to $375.69 in Nasdaq midday trading Tuesday after swinging between $340.46 and $377.65. The company said Chief Accounting Officer Matthew Sepe will retire after the Feb. 6 filing of its quarterly report, with Eric Chang named as successor. About 3.1 million shares traded by midday. Lumentum will release fiscal second-quarter results on Feb. 3.
6 January 2026
··
Citigroup stock holds near 52-week high as Barclays lifts target to $146 ahead of earnings

Citigroup stock holds near 52-week high as Barclays lifts target to $146 ahead of earnings

Citigroup shares edged up 0.1% to $123.42 Tuesday after Barclays raised its price target to $146. Citi hit a 52-week high Monday, closing at $123.30 on heavy volume. The bank will report fourth-quarter results Jan. 14, with analysts expecting earnings of $1.77 per share on $21 billion revenue. Citi disclosed a pre-tax loss from its Russia exit but said it will not affect key capital ratios.
6 January 2026
··
UnitedHealth stock jumps on TPG-Optum UK deal report as Jan. 27 earnings loom

UnitedHealth stock jumps on TPG-Optum UK deal report as Jan. 27 earnings loom

UnitedHealth Group shares rose 2.1% to $349.25 after reports TPG neared a deal to buy its Optum UK unit, valuing the business at up to £1.4 billion. The move boosted the Dow, with UnitedHealth and Amazon contributing 87 points to a 218-point gain. The company will report full-year 2025 results and 2026 guidance on Jan. 27. The Optum UK sale is not finalized and could still fall through.
6 January 2026
··
SoFi stock drops below $30 after $1.59 billion share sale as options traders brace for a 13.7% earnings swing

SoFi stock drops below $30 after $1.59 billion share sale as options traders brace for a 13.7% earnings swing

SoFi Technologies shares dropped 8.9% to $26.68 after a $1.59 billion public offering of 57.8 million shares at $27.50 each. Underwriters included Goldman Sachs, BofA, Citigroup, Deutsche Bank, and Mizuho. Options activity surged, with call volume over three times normal and implied post-earnings moves near 14%. Wall Street remains split on valuation, with price targets ranging from $24 to $28.
6 January 2026
··
JPMorgan stock slips after record run as investors eye Jan. 13 earnings

JPMorgan stock slips after record run as investors eye Jan. 13 earnings

JPMorgan shares slipped 0.3% to $333 Tuesday, pulling back after Monday’s record high. The bank’s new Special Advisory Services unit drew attention, while investors await fourth-quarter results due January 13. JPMorgan’s board declared a $1.50 dividend payable January 31 to holders as of January 6. Cost pressures remain a risk, with 2026 expenses projected at $105 billion.
6 January 2026
··
Tesla stock slides on Europe sales slump as BYD gains; traders eye Jan. 28 earnings

Tesla stock slides on Europe sales slump as BYD gains; traders eye Jan. 28 earnings

Tesla shares fell 3.2% to $437.13 Tuesday after German data showed December sales dropped 48% year-on-year. UK registrations slid 29% as Chinese rival BYD surged. Tesla lost its global EV sales lead to BYD after a second annual decline. Investors are watching for growth in AI and autonomous driving as EV demand slows.
6 January 2026
····
Spotify stock premarket: SPOT steadies near $600 as earnings, pricing loom

Spotify stock premarket: SPOT steadies near $600 as earnings, pricing loom

Spotify shares edged up 0.1% to $593.99 in Tuesday premarket trading after a 3.2% gain Monday. The company will report fourth-quarter results on Feb. 10, with investors watching for updates on U.S. subscription price hikes and profit targets. Spotify recently launched music videos for premium users in the U.S. and Canada. A new lawsuit alleges paid automated streams on platforms including Spotify, though the company is not a defendant.
6 January 2026
··
1 … 110 111 112 113 114 … 202

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Go toTop